Le Lézard
Classified in: Covid-19 virus
Subject: ATY

QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - QDEL


NEW YORK, April 26, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ: QDEL).

Shareholders who purchased shares of QDEL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/quidelortho-loss-submission-form/?id=76959&from=4

CLASS PERIOD: February 18, 2022 to April 1, 2024

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (a) that QuidelOrtho sold more COVID-19 tests to its distributors and pharmacy chain customers than they could resell to healthcare providers and end customers; (b) that excess inventories of COVID-19 tests existed throughout the supply chain; (c) that, as a result of (a)-(b) above, QuidelOrtho's distributors and pharmacy chain customers were poised to significantly reduce their COVID-19 test orders; (d) that undisclosed problems created a heightened risk that the new test called the savanna respiratory viral panel-4 test would experience a delayed commercial launch in the united states; (e) that, as a result of (a)-(d) above, defendants lacked a reasonable basis for their positive statements about QuidelOrtho's business, financials, and growth trajectory.

DEADLINE: June 11, 2024 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/quidelortho-loss-submission-form/?id=76959&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of QDEL during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is June 11, 2024. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

SOURCE The Gross Law Firm


These press releases may also interest you

at 10:31
According to a new market research report titled, 'Lab Automation Market Size, Share, Forecast, & Trends Analysis by Product (Liquid Handling, Nucleic Acid Purification System, Microplate Reader, ELISA, LIMS, ELN) Application (Drug Discovery,...

at 10:30
Bristol Myers Squibb today announced new four-year results from the POETYK PSO long-term extension (LTE) trial of Sotyktu (deucravacitinib) treatment in adult patients with moderate-to-severe plaque psoriasis. After four years of continuous...

at 10:30
American education is at a crossroads. Woke teachers refuse to teach American history. Literacy rates are plummeting. Since the COVID-19 shutdown, school attendance has dramatically declined. Conservatives are standing up, running for school board...

at 10:15
Bayer will present new data across its oncology portfolio at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting, taking place in Chicago, from May 31 ? June 4, 2024. The breadth of new data in different tumor types underscores...

at 10:15
The global breakfast food market size is estimated to grow by USD 125 bn from 2023-2027, according to Technavio. The market is estimated to grow at a CAGR of 5.31% during the forecast period. ...

at 10:01
The global risk management software market size is estimated to grow by USD 7372.29 mn from 2023-2027, according to Technavio. The market is estimated to grow at a CAGR of 15.32% during the forecast period. ...



News published on and distributed by: